Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 20

1.

Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.

Fielding JE, Grant KA, Papadakis G, Kelly HA.

BMC Infect Dis. 2011 Jun 14;11:170. doi: 10.1186/1471-2334-11-170.

2.

Influenza vaccine 2008-2009.

[No authors listed]

Med Lett Drugs Ther. 2008 Oct 6;50(1296):77-9. Review.

PMID:
18833032
3.

Influenza vaccine: the challenge of antigenic drift.

Carrat F, Flahault A.

Vaccine. 2007 Sep 28;25(39-40):6852-62. Epub 2007 Aug 3. Review.

PMID:
17719149
4.

Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.

Yin JK, Chow MY, Khandaker G, King C, Richmond P, Heron L, Booy R.

Vaccine. 2012 May 2;30(21):3209-22. doi: 10.1016/j.vaccine.2012.02.048. Epub 2012 Mar 2. Review.

PMID:
22387221
5.

The rationale for quadrivalent influenza vaccines.

Ambrose CS, Levin MJ.

Hum Vaccin Immunother. 2012 Jan;8(1):81-8. doi: 10.4161/hv.8.1.17623. Epub 2012 Jan 1. Review.

6.

Influenza guideline for South Africa--update 2008.

Green RJ, Feldman C, Schoub B, Richards GA, Madhi SA, Zar HJ, Lalloo U; Guideline Committee of 1999, Klugman K, Phillips D, Cameron NA, Eggers RR.

S Afr Med J. 2008 Mar;98(3 Pt 2):224-30. Review.

PMID:
18652399
7.

Recommendations for prevention and control of influenza in children, 2013-2014.

Committee on infectious diseases.

Pediatrics. 2013 Oct;132(4):e1089-104. doi: 10.1542/peds.2013-2377. Epub 2013 Sep 2. Review.

8.

Vaccination and antigenic drift in influenza.

Boni MF.

Vaccine. 2008 Jul 18;26 Suppl 3:C8-14. Review.

9.

Influenza vaccine: an effective preventive vaccine for developing countries.

Verma R, Khanna P, Chawla S.

Hum Vaccin Immunother. 2012 May;8(5):675-8. doi: 10.4161/hv.19516. Epub 2012 May 1. Review.

PMID:
22634439
10.

Clinical and socioeconomic impact of pediatric seasonal and pandemic influenza.

Marchisio P, Baggi E, Bianchini S, Principi N, Esposito S.

Hum Vaccin Immunother. 2012 Jan;8(1):17-20. doi: 10.4161/hv.8.1.18145. Epub 2012 Jan 1. Review.

PMID:
22252002
11.

Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Sullivan SG, Feng S, Cowling BJ.

Expert Rev Vaccines. 2014 Dec;13(12):1571-91. doi: 10.1586/14760584.2014.966695. Epub 2014 Oct 28. Review.

12.

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.

Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ.

Vaccine. 2008 Sep 12;26 Suppl 4:D31-4. Review.

PMID:
19230156
13.

Prevention and control of influenza and dengue through vaccine development.

Greenberg DP, Robertson CA, Gordon DM.

Pediatr Ann. 2013 Aug;42(8):172-7. doi: 10.3928/00904481-20130723-12. Review.

PMID:
23910031
14.

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review.

Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V.

Lancet. 2005 Oct 1;366(9492):1165-74. Epub 2005 Sep 22. Review. Erratum in: Lancet. 2006 Mar 25;367(9515):986.

PMID:
16198765
15.

Influenza vaccine for 2015-2016.

[No authors listed]

Med Lett Drugs Ther. 2015 Sep 14;57(1477):125-7. Review. No abstract available.

PMID:
26353043
16.

Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic.

Minodier L, Blanchon T, Souty C, Turbelin C, Leccia F, Varesi L, Falchi A.

Expert Rev Vaccines. 2014 Aug;13(8):1039-48. doi: 10.1586/14760584.2014.930666. Epub 2014 Jun 19. Review.

PMID:
24946796
17.

Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories.

Hensley SE.

Curr Opin Virol. 2014 Oct;8:85-9. doi: 10.1016/j.coviro.2014.07.007. Epub 2014 Aug 11. Review.

18.

Assessing vaccine efficacy in influenza clinical trials: challenges and difficulties.

Dewe W, Benoit A, Legrand C.

Expert Rev Clin Pharmacol. 2013 Jul;6(4):403-11. doi: 10.1586/17512433.2013.811817. Review.

PMID:
23927668
19.

[Immune system and influenza virus].

Wierzbicka-Woś A, Tokarz-Deptuła B, Deptuła W.

Postepy Hig Med Dosw (Online). 2015 Feb 15;69:214-20. doi: 10.5604/17322693.1140337. Review. Polish.

PMID:
25720607
20.

Observational methods in epidemiologic assessment of vaccine effectiveness.

Torvaldsen S, McIntyre PB.

Commun Dis Intell Q Rep. 2002;26(3):451-7. Review.

PMID:
12416713
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk